20250213485. Oral Dosing Glp-1 Compound (Novo Nordisk A/S)
Appearance
Oral Dosing of GLP-1 Compounds
Abstract: the present invention relates to improved uses of glp-1 peptides in oral therapy.
Inventor(s): Flemming S. Nielsen, Per Sauerberg
CPC Classification: A61K9/2013 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))
Search for rejections for patent application number 20250213485